DDX53 and colorectal carcinoma: The therapeutic effect of immunotherapy on the excluded-type CRC liver metastases with abundant stromal components was investigated by performing a therapeutic experiment using a liver metastasis mouse model, in which both the CAFs and CT26 cells were co-transplanted into the spleens (Figure 3a,b).